OLVOXA
LIVE

Serial Number

79273193

Owner

BIOFARMA

Attorney

Maury M. Tepper, III

Filing Date

Sep 16, 2019

Add to watchlist:

No watchlists yet
View on USPTO

OLVOXA Trademark

Serial Number: 79273193 • Registration: 6166336

OLVOXA is a trademark filed by BIOFARMA on September 16, 2019. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

BIOFARMA (296 trademarks)

50, rue Carnot
Suresnes cedex 92284 , FR

Entity Type: 03

Trademark Details

Filing Date

September 16, 2019

Registration Date

October 6, 2020

Published for Opposition

July 21, 2020

Goods & Services

Computer hardware and recorded software sold as a unit for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; downloadable computer software for controlling and managing patient medical information; downloadable computer programs for providing information on health and well-being; downloadable computer software enabling users to keep track of their symptoms, physical activity and vital signs and to record and share information with healthcare professionals; downloadable mobile application software for healthcare professionals and patients containing health information and diagnostic data relating thereto, for use by healthcare professionals for monitoring and diagnosing medical conditions and the treatment thereof

Medical services; provision of medical testing services for diagnosis or treatment and of information in the field of personalized medical care; consultancy services relating to health; pharmaceutical consultancy; telemedicine services; medical diagnostic, monitoring and reporting services; advisory services relating to health; health screening services in the fields of human physiology, activity, sleep, sleep apnea, cardiovascular health, dermatology, hearing, neurology, cancer, endocrinology, hormones and metabolic health

Medical devices for monitoring vital signs, blood properties and respiratory events for medical use; diagnostic devices for medical use, namely, medical diagnostic instruments for the analysis of bodily fluids and medical diagnostic apparatus for testing DNA and RNA samples; physiological measuring and monitoring apparatus for medical use in the nature of medical apparatus for monitoring blood oxygen saturation, blood gas concentrations, blood properties and respiratory events; automatic analyzers for medical use, namely, skin moisture analyzers for medical purposes, analyzers for bacterial identification for medical purposes, and Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs, blood properties and respiratory events; health monitoring and surveillance devices consisting of blood pressure monitors, thermometers, pedometers; electrical or electronic sensors for medical use to be worn by a human to gather human biometric data, specifically to detect, measure, process, collect, record and transmit health-related variables used to measure biometric data for medical use

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 6, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 14, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 25, 2021 FICS
FINAL DISPOSITION PROCESSED
Jan 25, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 6, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 6, 2020 R.PR
NOTIFICATION PROCESSED BY IB
Jul 31, 2020 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 21, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 21, 2020 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 15, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 15, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 1, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 15, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 11, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 11, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 11, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 11, 2020 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 10, 2020 GNFN
FINAL REFUSAL E-MAILED
Jun 10, 2020 GNFR
FINAL REFUSAL WRITTEN
Jun 10, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 18, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 18, 2020 CRFA
ASSIGNED TO LIE
May 18, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 12, 2020 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 21, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 21, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 21, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 21, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 21, 2020 COAR
REFUSAL PROCESSED BY IB
Feb 1, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 11, 2020 RFCS
REFUSAL PROCESSED BY MPU
Jan 11, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 18, 2019 RFCR
NON-FINAL ACTION WRITTEN
Dec 17, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Dec 17, 2019 MAFR
ASSIGNED TO EXAMINER
Dec 16, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 13, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 12, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 5, 2019 REPR